首页> 外国专利> VEGF FUSION PROTEIN AND EXPRESSION VECTOR THEROF FOR TREATMENT OF VEGF DEPENDENT DISEASE

VEGF FUSION PROTEIN AND EXPRESSION VECTOR THEROF FOR TREATMENT OF VEGF DEPENDENT DISEASE

机译:VEGF融合蛋白和表达载体治疗VEGF依赖性疾病的治疗

摘要

PURPOSE: A VEGF(vascular endothelial growth factor) fusion protein and expression vector thereof for treating VEGF dependent disease are provided. The vector expresses VEGF in high yield when transfected into eukaryotes, especially mammary culture cells and when injected into the tissue in vivo. CONSTITUTION: An expression vector for eukaryotes, which expresses fusion protein, is characterized by jointing partial gene or whole gene which codes a fusion protein, into partial gene or whole gene which codes VEGF isoform protein. The gene coding fusion protein is characterized by immunoglobulin gene(IgG). The IgG gene is characterized by Fc section of human IgG. The VEGF gene is cDNA of VEGF121 protein and expression vector pCN-VEGF/Fc for eucaryotes is represented by the figure 2. Transformed recombinant E.coli strain, Top10-pCN-VEGF/Fc (KFCC-11082) is transformed with the pCN-VEGF/Fc vector.
机译:目的:提供一种用于治疗VEGF依赖性疾病的VEGF(血管内皮生长因子)融合蛋白及其表达载体。当转染到真核生物中,尤其是在乳腺培养细胞中,并且在体内注射到组织中时,该载体以高产率表达VEGF。组成:表达融合蛋白的真核生物表达载体,其特征在于将编码融合蛋白的部分基因或整个基因与编码VEGF同工型蛋白的部分基因或整个基因连接在一起。编码融合蛋白的基因以免疫球蛋白基因(IgG)为特征。 IgG基因的特征在于人IgG的Fc部分。 VEGF基因是VEGF121蛋白的cDNA,真核表达载体pCN-VEGF / Fc由图2表示。转化的重组大肠杆菌菌株Top10-pCN-VEGF / Fc(KFCC-11082)用pCN-转化。 VEGF / Fc载体。

著录项

  • 公开/公告号KR20000071891A

    专利类型

  • 公开/公告日2000-12-05

    原文格式PDF

  • 申请/专利权人 KIM SUN YOUNG;

    申请/专利号KR19990015791

  • 发明设计人 LEE SU JEONG;LEE YEONG JU;

    申请日1999-05-01

  • 分类号C12N15/63;A61K38/00;

  • 国家 KR

  • 入库时间 2022-08-22 01:14:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号